荧光素眼底血管造影评估既往接受抗血管内皮生长因子单药治疗的早产儿视网膜病变患儿
该研究回顾性分析2016年6月至2021年9月转诊至作者诊所、1岁及以上首次行荧光素眼底血管造影的早产儿视网膜病变患儿,共250例486眼,均为曾接受单剂抗血管内皮生长因子单药治疗者。造影显示83眼(17.1%)血管终止于II区、403眼(82.9%)终止于III区,并见环周血管、指状突起异常、高荧光、细分枝伴钝性终止及动静脉短路等异常。作者认为治疗后期行荧光素眼底血管造影可清晰界定血管终点并发现间接检眼镜无法发现的异常,随访有助于预防导致视力丧失的并发症。
要点
- 486眼中403眼(82.9%)血管终止于III区,83眼(17.1%)终止于II区。
- 异常表现包括环周血管41.2%、指状突起异常36.2%、高荧光16.9%、细分枝伴钝性终止15%、动静脉短路9.9%。
- 作者认为治疗后期荧光素眼底血管造影可发现间接检眼镜无法发现的异常。
核心结论
- 在曾接受单剂抗血管内皮生长因子单药治疗的早产儿视网膜病变患儿中,治疗后期行荧光素眼底血管造影可清晰界定血管终点,并发现间接检眼镜无法检测的异常;作者认为荧光素眼底血管造影随访有助于预防可导致视力丧失的并发症。
研究设计与样本
- 回顾性分析2016年6月至2021年9月转诊至作者诊所行荧光素眼底血管造影检查的患儿资料。
- 纳入1岁或以上首次行荧光素眼底血管造影检查、因侵袭性早产儿视网膜病变或1型早产儿视网膜病变接受单剂抗血管内皮生长因子治疗的患者。
- 共纳入250例患者486眼。
主要发现
- 83眼(17.1%)血管终止于II区,403眼(82.9%)血管终止于III区。
- 62.7%的眼中血管终点至颞侧锯齿缘距离小于两个视盘直径,20.2%的眼中该距离大于两个视盘直径。
- 异常血管表现包括环周血管(41.2%)、指状突起异常(36.2%)、高荧光(16.9%)、细分枝和钝性终止(15%)及动静脉短路(9.9%)。
临床怎么用
- 作者认为,治疗后期行荧光素眼底血管造影可清晰界定血管终点并检出间接检眼镜无法发现的异常。
- 作者认为,荧光素眼底血管造影随访有助于预防可导致视力丧失的并发症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine the level of vascularization and peripheral vascular findings by fluorescence angiography in patients with aggressive retinopathy of prematurity or Type 1 retinopathy of prematurity treated with a single dose of anti-vascular endothelial growth factor. METHODS: Data of patients referred to the authors' clinic for fluorescence angiography examination between June 2016 and September 2021 were retrospectively analyzed. Patients who had their first fluorescence angiography examination at the age of 1 year or older were included in the study. RESULTS: A total of 486 eyes of 250 patients were included. Of these, 83 eyes (17.1%) had vascular termination in Zone II and 403 eyes (82.9%) in Zone III. In 62.7% of eyes, the distance from the vascular terminals to the temporal ora serrata was less than two disk diameters, and in 20.2%, it was more than two disk diameters. Abnormal vascular findings were noted, including circumferential vessels (41.2%), finger-like projection anomaly (36.2%), hyperfluorescence (16.9%), fine branching and blunt termination (15%), and arteriovenous shunt (9.9%). CONCLUSION: Fluorescence angiography performed late in the course of treatment can clearly define the vascular termini and detect abnormalities that cannot be detected by indirect ophthalmoscopy. Follow-up with fluorescence angiography can help prevent complications that can lead to vision loss.
引用
- Poslu Karademir F, Vural A, Özbaş M, et al. FLUORESCEIN ANGIOGRAPHY EVALUATION OF CHILDREN PREVIOUSLY TREATED WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR MONOTHERAPY FOR RETINOPATHY OF PREMATURITY. Retina. 2024. PMID: 38150651. doi:10.1097/IAE.0000000000004032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。